| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/28/2009 | US20090137559 Bazedoxifene ascorbate |
| 05/28/2009 | US20090137555 activity of CDK1, CDK2, CDK4, CDK5, GSK3 beta , Bcr-ab1, Flt-3, c-Kit, PDGFR beta , Src, Mek1 and CK1; 2-[N'-(2,3-dibromo-8-oxo-5,6,7,8-tetrahydro-1H-pyrrolo[2,3-c]azepin-4-ylidene)-hydrazino]-benzoic acid; antiinflammatory agent; autoimmune, neurological, cardiovasculal, hormone-related diseases |
| 05/28/2009 | US20090137552 Organic Compound |
| 05/28/2009 | US20090137532 Aldolase-inhibiting aromatic compounds |
| 05/28/2009 | US20090137521 Certain Compounds, Compositions and Methods |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137503 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 05/28/2009 | US20090137494 Tumor-activated prodrug compounds and treatment |
| 05/28/2009 | US20090137493 Inhibition of tumor metastases using protein kinase C (PKC) inhibitors |
| 05/28/2009 | US20090137482 Biologically active peptide and agent containing the same |
| 05/28/2009 | US20090137476 Apo-2 ligand variants and uses thereof |
| 05/28/2009 | US20090137473 Inhibition of microtubule protrusion in cancer cells |
| 05/28/2009 | US20090137470 Methods of treating cancer using notch pathway inhibitors |
| 05/28/2009 | US20090137468 Cytotoxic factors for modulating cell death |
| 05/28/2009 | US20090137453 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 05/28/2009 | US20090137451 Methods for Assessing Suitability of Cancer Patients for Treatment with Histone Deacetylase Inhibitors |
| 05/28/2009 | US20090137412 Chromogenic in situ hybridization methods, kits, and compositions |
| 05/28/2009 | US20090137036 Tweak receptor |
| 05/28/2009 | US20090137035 Tweak receptor |
| 05/28/2009 | US20090137002 Anti ephb4 antibodies and antibody fragments |
| 05/28/2009 | US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases |
| 05/28/2009 | US20090136980 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136939 Methods for diagnosis and therapy for pancreatic cancer and composition useful therein |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136566 Therapeutic triterpenoids |
| 05/28/2009 | US20090136556 System And Method For Coating Implantable Devices |
| 05/28/2009 | US20090136528 Novel immunogenic epitope for immunotherapy |
| 05/28/2009 | US20090136527 Synthetic peptide comprising the amino acid sequence GPRLGYSWHX in which each of the amino acids are in the D-amino acid configuration and X is any amino acid; optionally conjugated to the natural gonadotropin-releasing hormone peptide; vaccines for use incontrolling fertility or heat in an animal |
| 05/28/2009 | US20090136524 Compositions and methods for diagnosis and treatment of tumors |
| 05/28/2009 | US20090136520 Mitochondrial localization of muc1 |
| 05/28/2009 | US20090136517 Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit |
| 05/28/2009 | US20090136513 Bicyclo-pyrazoles active as kinase inhibitors |
| 05/28/2009 | US20090136508 Method of diagnosing colon and gastric cancers |
| 05/28/2009 | US20090136502 Preventives/Remedies for Cancer |
| 05/28/2009 | US20090136499 RAF Inhibitors and Uses Thereof |
| 05/28/2009 | US20090136496 Chronic lymphocytic leukemia prognosis and treatment |
| 05/28/2009 | US20090136494 Combination therapies employing GITR binding molecules |
| 05/28/2009 | US20090136489 Methods for the treatment, diagnosis, and prognosis of cancer |
| 05/28/2009 | US20090136487 Bmx mediated signal transduction in irradiated vascular endothelium |
| 05/28/2009 | US20090136486 Biomarkers for human papilloma virus-associated cancer |
| 05/28/2009 | US20090136485 Methods and compositions for inhibiting CD32B expressing cells |
| 05/28/2009 | US20090136484 Novel antibody molecules and nucleic acids |
| 05/28/2009 | US20090136483 Compositions and Methods for Binding Lysophosphatidic Acid |
| 05/28/2009 | US20090136478 Methods for using enzymes to disintegrate cancerous tumors in vivo |
| 05/28/2009 | US20090136475 Immunokinases |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090136458 Renal Carcinoma Cell Line and Uses thereof |
| 05/28/2009 | US20090136451 Humanised Baculovirus |
| 05/28/2009 | US20090136431 Stilbene Like Compounds as Novel HDAC Inhibitors |
| 05/28/2009 | US20090136421 PAI-2 conjugates for the treatment and imaging of cancer |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | US20090136419 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/28/2009 | DE102007056424A1 Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion A pharmaceutical composition containing an oil / water emulsion |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
| 05/28/2009 | CA2706102A1 Small-molecule modulators of trp-p8 activity |
| 05/28/2009 | CA2706075A1 Cancer diagnostic and therapeutic methods that target plk4/sak |
| 05/28/2009 | CA2705944A1 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 05/28/2009 | CA2705588A1 System for delivery into a xcr1 positive cell and uses thereof |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | CA2703893A1 Compound |
| 05/28/2009 | CA2703283A1 Method for treating hematopoietic neoplasms |
| 05/28/2009 | CA2699306A1 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
| 05/28/2009 | CA2699305A1 Polymorphs of sunitinib base and processes for preparation thereof |
| 05/28/2009 | CA2695605A1 Pyrazolone derivative emulsion formulations |
| 05/27/2009 | EP2062971A1 Chimeric adenovirus, method for producing the same and pharmaceutical using the same |
| 05/27/2009 | EP2062919A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062918A2 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 05/27/2009 | EP2062914A2 Somatostatin-dopamine chimeric analogs |
| 05/27/2009 | EP2062893A1 Fused imidazoles for cancer treatment |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062887A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 05/27/2009 | EP2062886A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 05/27/2009 | EP2062885A1 Acid addition salts of imatinib and formulations comprising the same |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062597A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 05/27/2009 | EP2062596A1 Anti-tumor agent |
| 05/27/2009 | EP2062592A1 System for delivery into a XCR1 positive cell and uses thereof |
| 05/27/2009 | EP2062584A1 Adhesive preparation |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2062577A1 Oleanolic acid derivatives as NO production inhibitors |
| 05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
| 05/27/2009 | EP2061795A2 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061790A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 05/27/2009 | EP2061786A2 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 05/27/2009 | EP2061782A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 05/27/2009 | EP2061772A2 Multi-functional small molecules as anti-proliferative agents |
| 05/27/2009 | EP2061768A2 Imidazole-4,5-dicarboxamide derivatives as jak-2 modulators |
| 05/27/2009 | EP2061761A1 Phenethylamide derivatives with kinase inhibitory activity |
| 05/27/2009 | EP2061749A1 Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate |
| 05/27/2009 | EP2061561A1 Methods and compositions for treating cancer |
| 05/27/2009 | EP2061514A2 An aqueous formulation for selective targeting and delivering gene to cancer cells |
| 05/27/2009 | EP2061510A1 Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |